Global and United States Glycopyrrolate Tablets Market Report & Forecast 2022-2028

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Market Analysis and Insights: Global and United States Glycopyrrolate Tablets Market
This report focuses on global and United States Glycopyrrolate Tablets market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Glycopyrrolate Tablets market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, 0.5mg accounting for % of the Glycopyrrolate Tablets global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospitals was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Glycopyrrolate Tablets market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period  2022-2028.

Global Glycopyrrolate Tablets Scope and Market Size
Glycopyrrolate Tablets market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Glycopyrrolate Tablets market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Glycopyrrolate Tablets market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    0.5mg
    1mg
    2mg

Segment by Application
    Hospitals
    Clinics
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Rising Pharmaceuticals
    Kinedexe UK
    Intas Pharmaceutical
    Aurobindo Pharma USA
    Edenbridge Pharmaceuticals
    Heritage Pharmaceuticals
    Ranbaxy Pharmaceuticals
    Sciele Pharma
    Boca Pharmacal
    Solco Healthcare
    Natco Pharma
    Dr. Reddy’s Laboratories
    Dongting Pharmaceutical
    Alembic Labs
    Leading Pharma
    LGM Pharma Solutions
    Nexgen Pharma
    Par Pharmaceutical

 1 Study Coverage
    1.1 Glycopyrrolate Tablets Product Introduction
    1.2 Global Glycopyrrolate Tablets Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Glycopyrrolate Tablets Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Glycopyrrolate Tablets Sales in Volume for the Year 2017-2028
    1.3 United States Glycopyrrolate Tablets Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Glycopyrrolate Tablets Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Glycopyrrolate Tablets Sales in Volume for the Year 2017-2028
    1.4 Glycopyrrolate Tablets Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Glycopyrrolate Tablets in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Glycopyrrolate Tablets Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Glycopyrrolate Tablets Market Dynamics
        1.5.1 Glycopyrrolate Tablets Industry Trends
        1.5.2 Glycopyrrolate Tablets Market Drivers
        1.5.3 Glycopyrrolate Tablets Market Challenges
        1.5.4 Glycopyrrolate Tablets Market Restraints
    1.6 Study Objectives
    1.7 Years Considered

 2 Market by Type
    2.1 Glycopyrrolate Tablets Market Segment by Type
        2.1.1 0.5mg
        2.1.2 1mg
        2.1.3 2mg
    2.2 Global Glycopyrrolate Tablets Market Size by Type
        2.2.1 Global Glycopyrrolate Tablets Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Glycopyrrolate Tablets Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Glycopyrrolate Tablets Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Glycopyrrolate Tablets Market Size by Type
        2.3.1 United States Glycopyrrolate Tablets Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Glycopyrrolate Tablets Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Glycopyrrolate Tablets Average Selling Price (ASP) by Type (2017, 2022 & 2028)

 3 Market by Application
    3.1 Glycopyrrolate Tablets Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Clinics
        3.1.3 Others
    3.2 Global Glycopyrrolate Tablets Market Size by Application
        3.2.1 Global Glycopyrrolate Tablets Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Glycopyrrolate Tablets Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Glycopyrrolate Tablets Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Glycopyrrolate Tablets Market Size by Application
        3.3.1 United States Glycopyrrolate Tablets Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Glycopyrrolate Tablets Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Glycopyrrolate Tablets Average Selling Price (ASP) by Application (2017, 2022 & 2028)

 4 Global Glycopyrrolate Tablets Competitor Landscape by Company
    4.1 Global Glycopyrrolate Tablets Market Size by Company
        4.1.1 Top Global Glycopyrrolate Tablets Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Glycopyrrolate Tablets Revenue by Manufacturer (2017-2022)
        4.1.3 Global Glycopyrrolate Tablets Sales by Manufacturer (2017-2022)
        4.1.4 Global Glycopyrrolate Tablets Price by Manufacturer (2017-2022)
    4.2 Global Glycopyrrolate Tablets Concentration Ratio (CR)
        4.2.1 Glycopyrrolate Tablets Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Glycopyrrolate Tablets in 2021
        4.2.3 Global Glycopyrrolate Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Glycopyrrolate Tablets Manufacturing Base Distribution, Product Type
        4.3.1 Global Glycopyrrolate Tablets Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Glycopyrrolate Tablets Product Type
        4.3.3 Date of International Manufacturers Enter into Glycopyrrolate Tablets Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Glycopyrrolate Tablets Market Size by Company
        4.5.1 Top Glycopyrrolate Tablets Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Glycopyrrolate Tablets Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Glycopyrrolate Tablets Sales by Players (2020, 2021 & 2022)

 5 Global Glycopyrrolate Tablets Market Size by Region
    5.1 Global Glycopyrrolate Tablets Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Glycopyrrolate Tablets Market Size in Volume by Region (2017-2028)
        5.2.1 Global Glycopyrrolate Tablets Sales in Volume by Region: 2017-2022
        5.2.2 Global Glycopyrrolate Tablets Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Glycopyrrolate Tablets Market Size in Value by Region (2017-2028)
        5.3.1 Global Glycopyrrolate Tablets Sales in Value by Region: 2017-2022
        5.3.2 Global Glycopyrrolate Tablets Sales in Value by Region: 2023-2028

 6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Glycopyrrolate Tablets Market Size YoY Growth 2017-2028
        6.1.2 North America Glycopyrrolate Tablets Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 United States
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Glycopyrrolate Tablets Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Glycopyrrolate Tablets Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 China Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
    6.3 Europe
        6.3.1 Europe Glycopyrrolate Tablets Market Size YoY Growth 2017-2028
        6.3.2 Europe Glycopyrrolate Tablets Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Glycopyrrolate Tablets Market Size YoY Growth 2017-2028
        6.4.2 Latin America Glycopyrrolate Tablets Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
        6.4.6 Colombia
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Glycopyrrolate Tablets Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Glycopyrrolate Tablets Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE

 7 Company Profiles
    7.1 Rising Pharmaceuticals
        7.1.1 Rising Pharmaceuticals Corporation Information
        7.1.2 Rising Pharmaceuticals Description and Business Overview
        7.1.3 Rising Pharmaceuticals Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Rising Pharmaceuticals Glycopyrrolate Tablets Products Offered
        7.1.5 Rising Pharmaceuticals Recent Development
    7.2 Kinedexe UK
        7.2.1 Kinedexe UK Corporation Information
        7.2.2 Kinedexe UK Description and Business Overview
        7.2.3 Kinedexe UK Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Kinedexe UK Glycopyrrolate Tablets Products Offered
        7.2.5 Kinedexe UK Recent Development
    7.3 Intas Pharmaceutical
        7.3.1 Intas Pharmaceutical Corporation Information
        7.3.2 Intas Pharmaceutical Description and Business Overview
        7.3.3 Intas Pharmaceutical Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Intas Pharmaceutical Glycopyrrolate Tablets Products Offered
        7.3.5 Intas Pharmaceutical Recent Development
    7.4 Aurobindo Pharma USA
        7.4.1 Aurobindo Pharma USA Corporation Information
        7.4.2 Aurobindo Pharma USA Description and Business Overview
        7.4.3 Aurobindo Pharma USA Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Aurobindo Pharma USA Glycopyrrolate Tablets Products Offered
        7.4.5 Aurobindo Pharma USA Recent Development
    7.5 Edenbridge Pharmaceuticals
        7.5.1 Edenbridge Pharmaceuticals Corporation Information
        7.5.2 Edenbridge Pharmaceuticals Description and Business Overview
        7.5.3 Edenbridge Pharmaceuticals Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Edenbridge Pharmaceuticals Glycopyrrolate Tablets Products Offered
        7.5.5 Edenbridge Pharmaceuticals Recent Development
    7.6 Heritage Pharmaceuticals
        7.6.1 Heritage Pharmaceuticals Corporation Information
        7.6.2 Heritage Pharmaceuticals Description and Business Overview
        7.6.3 Heritage Pharmaceuticals Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Heritage Pharmaceuticals Glycopyrrolate Tablets Products Offered
        7.6.5 Heritage Pharmaceuticals Recent Development
    7.7 Ranbaxy Pharmaceuticals
        7.7.1 Ranbaxy Pharmaceuticals Corporation Information
        7.7.2 Ranbaxy Pharmaceuticals Description and Business Overview
        7.7.3 Ranbaxy Pharmaceuticals Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 Ranbaxy Pharmaceuticals Glycopyrrolate Tablets Products Offered
        7.7.5 Ranbaxy Pharmaceuticals Recent Development
    7.8 Sciele Pharma
        7.8.1 Sciele Pharma Corporation Information
        7.8.2 Sciele Pharma Description and Business Overview
        7.8.3 Sciele Pharma Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 Sciele Pharma Glycopyrrolate Tablets Products Offered
        7.8.5 Sciele Pharma Recent Development
    7.9 Boca Pharmacal
        7.9.1 Boca Pharmacal Corporation Information
        7.9.2 Boca Pharmacal Description and Business Overview
        7.9.3 Boca Pharmacal Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2017-2022)
        7.9.4 Boca Pharmacal Glycopyrrolate Tablets Products Offered
        7.9.5 Boca Pharmacal Recent Development
    7.10 Solco Healthcare
        7.10.1 Solco Healthcare Corporation Information
        7.10.2 Solco Healthcare Description and Business Overview
        7.10.3 Solco Healthcare Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2017-2022)
        7.10.4 Solco Healthcare Glycopyrrolate Tablets Products Offered
        7.10.5 Solco Healthcare Recent Development
    7.11 Natco Pharma
        7.11.1 Natco Pharma Corporation Information
        7.11.2 Natco Pharma Description and Business Overview
        7.11.3 Natco Pharma Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2017-2022)
        7.11.4 Natco Pharma Glycopyrrolate Tablets Products Offered
        7.11.5 Natco Pharma Recent Development
    7.12 Dr. Reddy’s Laboratories
        7.12.1 Dr. Reddy’s Laboratories Corporation Information
        7.12.2 Dr. Reddy’s Laboratories Description and Business Overview
        7.12.3 Dr. Reddy’s Laboratories Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2017-2022)
        7.12.4 Dr. Reddy’s Laboratories Products Offered
        7.12.5 Dr. Reddy’s Laboratories Recent Development
    7.13 Dongting Pharmaceutical
        7.13.1 Dongting Pharmaceutical Corporation Information
        7.13.2 Dongting Pharmaceutical Description and Business Overview
        7.13.3 Dongting Pharmaceutical Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2017-2022)
        7.13.4 Dongting Pharmaceutical Products Offered
        7.13.5 Dongting Pharmaceutical Recent Development
    7.14 Alembic Labs
        7.14.1 Alembic Labs Corporation Information
        7.14.2 Alembic Labs Description and Business Overview
        7.14.3 Alembic Labs Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2017-2022)
        7.14.4 Alembic Labs Products Offered
        7.14.5 Alembic Labs Recent Development
    7.15 Leading Pharma
        7.15.1 Leading Pharma Corporation Information
        7.15.2 Leading Pharma Description and Business Overview
        7.15.3 Leading Pharma Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2017-2022)
        7.15.4 Leading Pharma Products Offered
        7.15.5 Leading Pharma Recent Development
    7.16 LGM Pharma Solutions
        7.16.1 LGM Pharma Solutions Corporation Information
        7.16.2 LGM Pharma Solutions Description and Business Overview
        7.16.3 LGM Pharma Solutions Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2017-2022)
        7.16.4 LGM Pharma Solutions Products Offered
        7.16.5 LGM Pharma Solutions Recent Development
    7.17 Nexgen Pharma
        7.17.1 Nexgen Pharma Corporation Information
        7.17.2 Nexgen Pharma Description and Business Overview
        7.17.3 Nexgen Pharma Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2017-2022)
        7.17.4 Nexgen Pharma Products Offered
        7.17.5 Nexgen Pharma Recent Development
    7.18 Par Pharmaceutical
        7.18.1 Par Pharmaceutical Corporation Information
        7.18.2 Par Pharmaceutical Description and Business Overview
        7.18.3 Par Pharmaceutical Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2017-2022)
        7.18.4 Par Pharmaceutical Products Offered
        7.18.5 Par Pharmaceutical Recent Development

 8 Industry Chain and Sales Channels Analysis
    8.1 Glycopyrrolate Tablets Industry Chain Analysis
    8.2 Glycopyrrolate Tablets Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Glycopyrrolate Tablets Distributors
    8.3 Glycopyrrolate Tablets Production Mode & Process
    8.4 Glycopyrrolate Tablets Sales and Marketing
        8.4.1 Glycopyrrolate Tablets Sales Channels
        8.4.2 Glycopyrrolate Tablets Distributors
    8.5 Glycopyrrolate Tablets Customers

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Glycopyrrolate Tablets CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Glycopyrrolate Tablets Market Trends
    Table 3. Glycopyrrolate Tablets Market Drivers
    Table 4. Glycopyrrolate Tablets Market Challenges
    Table 5. Glycopyrrolate Tablets Market Restraints
    Table 6. Global Glycopyrrolate Tablets Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Glycopyrrolate Tablets Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Glycopyrrolate Tablets Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Glycopyrrolate Tablets Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Glycopyrrolate Tablets Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Glycopyrrolate Tablets Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Glycopyrrolate Tablets Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Glycopyrrolate Tablets Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Glycopyrrolate Tablets Sales Share by Manufacturer, 2017-2022
    Table 15. Global Glycopyrrolate Tablets Price by Manufacturer (2017-2022) & (US$/Unit)
    Table 16. Global Glycopyrrolate Tablets Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Glycopyrrolate Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glycopyrrolate Tablets as of 2021)
    Table 18. Top Players of Glycopyrrolate Tablets in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Glycopyrrolate Tablets Product Type
    Table 20. Date of International Manufacturers Enter into Glycopyrrolate Tablets Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Glycopyrrolate Tablets Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Glycopyrrolate Tablets Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Glycopyrrolate Tablets Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Glycopyrrolate Tablets Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Glycopyrrolate Tablets Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Glycopyrrolate Tablets Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Glycopyrrolate Tablets Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Glycopyrrolate Tablets Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Glycopyrrolate Tablets Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Glycopyrrolate Tablets Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Glycopyrrolate Tablets Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Glycopyrrolate Tablets Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Glycopyrrolate Tablets Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Glycopyrrolate Tablets Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Glycopyrrolate Tablets Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Glycopyrrolate Tablets Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Glycopyrrolate Tablets Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Glycopyrrolate Tablets Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Glycopyrrolate Tablets Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Glycopyrrolate Tablets Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Rising Pharmaceuticals Corporation Information
    Table 43. Rising Pharmaceuticals Description and Business Overview
    Table 44. Rising Pharmaceuticals Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 45. Rising Pharmaceuticals Glycopyrrolate Tablets Product
    Table 46. Rising Pharmaceuticals Recent Development
    Table 47. Kinedexe UK Corporation Information
    Table 48. Kinedexe UK Description and Business Overview
    Table 49. Kinedexe UK Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 50. Kinedexe UK Product
    Table 51. Kinedexe UK Recent Development
    Table 52. Intas Pharmaceutical Corporation Information
    Table 53. Intas Pharmaceutical Description and Business Overview
    Table 54. Intas Pharmaceutical Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 55. Intas Pharmaceutical Product
    Table 56. Intas Pharmaceutical Recent Development
    Table 57. Aurobindo Pharma USA Corporation Information
    Table 58. Aurobindo Pharma USA Description and Business Overview
    Table 59. Aurobindo Pharma USA Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 60. Aurobindo Pharma USA Product
    Table 61. Aurobindo Pharma USA Recent Development
    Table 62. Edenbridge Pharmaceuticals Corporation Information
    Table 63. Edenbridge Pharmaceuticals Description and Business Overview
    Table 64. Edenbridge Pharmaceuticals Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 65. Edenbridge Pharmaceuticals Product
    Table 66. Edenbridge Pharmaceuticals Recent Development
    Table 67. Heritage Pharmaceuticals Corporation Information
    Table 68. Heritage Pharmaceuticals Description and Business Overview
    Table 69. Heritage Pharmaceuticals Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 70. Heritage Pharmaceuticals Product
    Table 71. Heritage Pharmaceuticals Recent Development
    Table 72. Ranbaxy Pharmaceuticals Corporation Information
    Table 73. Ranbaxy Pharmaceuticals Description and Business Overview
    Table 74. Ranbaxy Pharmaceuticals Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 75. Ranbaxy Pharmaceuticals Product
    Table 76. Ranbaxy Pharmaceuticals Recent Development
    Table 77. Sciele Pharma Corporation Information
    Table 78. Sciele Pharma Description and Business Overview
    Table 79. Sciele Pharma Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 80. Sciele Pharma Product
    Table 81. Sciele Pharma Recent Development
    Table 82. Boca Pharmacal Corporation Information
    Table 83. Boca Pharmacal Description and Business Overview
    Table 84. Boca Pharmacal Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 85. Boca Pharmacal Product
    Table 86. Boca Pharmacal Recent Development
    Table 87. Solco Healthcare Corporation Information
    Table 88. Solco Healthcare Description and Business Overview
    Table 89. Solco Healthcare Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 90. Solco Healthcare Product
    Table 91. Solco Healthcare Recent Development
    Table 92. Natco Pharma Corporation Information
    Table 93. Natco Pharma Description and Business Overview
    Table 94. Natco Pharma Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 95. Natco Pharma Product
    Table 96. Natco Pharma Recent Development
    Table 97. Dr. Reddy’s Laboratories Corporation Information
    Table 98. Dr. Reddy’s Laboratories Description and Business Overview
    Table 99. Dr. Reddy’s Laboratories Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 100. Dr. Reddy’s Laboratories Product
    Table 101. Dr. Reddy’s Laboratories Recent Development
    Table 102. Dongting Pharmaceutical Corporation Information
    Table 103. Dongting Pharmaceutical Description and Business Overview
    Table 104. Dongting Pharmaceutical Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 105. Dongting Pharmaceutical Product
    Table 106. Dongting Pharmaceutical Recent Development
    Table 107. Alembic Labs Corporation Information
    Table 108. Alembic Labs Description and Business Overview
    Table 109. Alembic Labs Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 110. Alembic Labs Product
    Table 111. Alembic Labs Recent Development
    Table 112. Leading Pharma Corporation Information
    Table 113. Leading Pharma Description and Business Overview
    Table 114. Leading Pharma Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 115. Leading Pharma Product
    Table 116. Leading Pharma Recent Development
    Table 117. LGM Pharma Solutions Corporation Information
    Table 118. LGM Pharma Solutions Description and Business Overview
    Table 119. LGM Pharma Solutions Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 120. LGM Pharma Solutions Product
    Table 121. LGM Pharma Solutions Recent Development
    Table 122. Nexgen Pharma Corporation Information
    Table 123. Nexgen Pharma Description and Business Overview
    Table 124. Nexgen Pharma Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 125. Nexgen Pharma Product
    Table 126. Nexgen Pharma Recent Development
    Table 127. Par Pharmaceutical Corporation Information
    Table 128. Par Pharmaceutical Description and Business Overview
    Table 129. Par Pharmaceutical Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 130. Par Pharmaceutical Product
    Table 131. Par Pharmaceutical Recent Development
    Table 132. Key Raw Materials Lists
    Table 133. Raw Materials Key Suppliers Lists
    Table 134. Glycopyrrolate Tablets Customers List
    Table 135. Glycopyrrolate Tablets Distributors List
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. Glycopyrrolate Tablets Product Picture
    Figure 2. Global Glycopyrrolate Tablets Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Glycopyrrolate Tablets Market Size 2017-2028 (US$ Million)
    Figure 4. Global Glycopyrrolate Tablets Sales 2017-2028 (K Units)
    Figure 5. United States Glycopyrrolate Tablets Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Glycopyrrolate Tablets Market Size 2017-2028 (US$ Million)
    Figure 7. United States Glycopyrrolate Tablets Sales 2017-2028 (K Units)
    Figure 8. United States Glycopyrrolate Tablets Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Glycopyrrolate Tablets Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Glycopyrrolate Tablets Report Years Considered
    Figure 11. Product Picture of 0.5mg
    Figure 12. Product Picture of 1mg
    Figure 13. Product Picture of 2mg
    Figure 14. Global Glycopyrrolate Tablets Market Share by Type in 2022 & 2028
    Figure 15. Global Glycopyrrolate Tablets Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Glycopyrrolate Tablets Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Glycopyrrolate Tablets Sales by Type (2017-2028) & (K Units)
    Figure 18. Global Glycopyrrolate Tablets Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Glycopyrrolate Tablets Price by Type (2017-2028) & (US$/Unit)
    Figure 20. United States Glycopyrrolate Tablets Market Share by Type in 2022 & 2028
    Figure 21. United States Glycopyrrolate Tablets Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Glycopyrrolate Tablets Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Glycopyrrolate Tablets Sales by Type (2017-2028) & (K Units)
    Figure 24. United States Glycopyrrolate Tablets Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Glycopyrrolate Tablets Price by Type (2017-2028) & (US$/Unit)
    Figure 26. Product Picture of Hospitals
    Figure 27. Product Picture of Clinics
    Figure 28. Product Picture of Others
    Figure 29. Global Glycopyrrolate Tablets Market Share by Application in 2022 & 2028
    Figure 30. Global Glycopyrrolate Tablets Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Glycopyrrolate Tablets Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Glycopyrrolate Tablets Sales by Application (2017-2028) & (K Units)
    Figure 33. Global Glycopyrrolate Tablets Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Glycopyrrolate Tablets Price by Application (2017-2028) & (US$/Unit)
    Figure 35. United States Glycopyrrolate Tablets Market Share by Application in 2022 & 2028
    Figure 36. United States Glycopyrrolate Tablets Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Glycopyrrolate Tablets Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Glycopyrrolate Tablets Sales by Application (2017-2028) & (K Units)
    Figure 39. United States Glycopyrrolate Tablets Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Glycopyrrolate Tablets Price by Application (2017-2028) & (US$/Unit)
    Figure 41. North America Glycopyrrolate Tablets Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 42. North America Glycopyrrolate Tablets Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. United States Glycopyrrolate Tablets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Glycopyrrolate Tablets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Glycopyrrolate Tablets Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 46. Europe Glycopyrrolate Tablets Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Glycopyrrolate Tablets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Glycopyrrolate Tablets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Glycopyrrolate Tablets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Glycopyrrolate Tablets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Glycopyrrolate Tablets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Glycopyrrolate Tablets Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 53. Asia-Pacific Glycopyrrolate Tablets Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Glycopyrrolate Tablets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Glycopyrrolate Tablets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Glycopyrrolate Tablets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Glycopyrrolate Tablets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Glycopyrrolate Tablets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. China Taiwan Glycopyrrolate Tablets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Glycopyrrolate Tablets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Glycopyrrolate Tablets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Glycopyrrolate Tablets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Latin America Glycopyrrolate Tablets Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 64. Latin America Glycopyrrolate Tablets Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 65. Mexico Glycopyrrolate Tablets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Brazil Glycopyrrolate Tablets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Argentina Glycopyrrolate Tablets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Colombia Glycopyrrolate Tablets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa Glycopyrrolate Tablets Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 70. Middle East & Africa Glycopyrrolate Tablets Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey Glycopyrrolate Tablets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia Glycopyrrolate Tablets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. UAE Glycopyrrolate Tablets Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Glycopyrrolate Tablets Value Chain
    Figure 75. Glycopyrrolate Tablets Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed

Market Analysis and Insights: Global and United States Glycopyrrolate Tablets Market
This report focuses on global and United States Glycopyrrolate Tablets market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Glycopyrrolate Tablets market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, 0.5mg accounting for % of the Glycopyrrolate Tablets global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospitals was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Glycopyrrolate Tablets market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period  2022-2028.

Global Glycopyrrolate Tablets Scope and Market Size
Glycopyrrolate Tablets market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Glycopyrrolate Tablets market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Glycopyrrolate Tablets market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    0.5mg
    1mg
    2mg

Segment by Application
    Hospitals
    Clinics
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Rising Pharmaceuticals
    Kinedexe UK
    Intas Pharmaceutical
    Aurobindo Pharma USA
    Edenbridge Pharmaceuticals
    Heritage Pharmaceuticals
    Ranbaxy Pharmaceuticals
    Sciele Pharma
    Boca Pharmacal
    Solco Healthcare
    Natco Pharma
    Dr. Reddy’s Laboratories
    Dongting Pharmaceutical
    Alembic Labs
    Leading Pharma
    LGM Pharma Solutions
    Nexgen Pharma
    Par Pharmaceutical